Tag Archives: MERS-CoV

How COVID-19 affects the nervous system | Instant News

A new paper published in the journal JAMA Neurology in May 2020 discussed the presentation and complications of COVID-19 with respect to the nervous system.

The COVID-19 pandemic has caused hundreds of thousands of cases of severe pneumonia and respiratory disorders, in 188 countries and regions in the world. The causative agent, SARS-CoV-2, is a new coronavirus, with well-recognized lung complications. However, evidence is increasing that the virus also affects other organs, such as the nervous system and heart.

The Coronaviruses: A Glimpse

That corona virus is a group of large spread RNA viruses that infect animals and humans. Human infections are known to be caused by 7 coronaviruses, namely human coronavirus (HCoV) –229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, MERS-CoV, SARS-CoV-1, and SARS-CoV-2.

Among these, the last three are known to cause severe human disease. While HCoV is more associated with respiratory manifestations, three of them are known to infect neurons: HCoV-229E, HCoV-OC43, and SARS-CoV-1.

Current research aims to contribute to the knowledge of the SARS-CoV-2 neurotropism, as well as post-infectious neurological complications. This virus infects humans through ACE2 receptors in various tissues, including airway epithelium, kidney cells, small intestine, proper lung tissue, and endothelial cells.

Because endothelium is found in blood vessels throughout the body, this offers a potential route for CoV to be localized in the brain. In addition, a recent report shows that ACE2 is also found in brain neurons, astrocytes, and oligodendrocytes, especially in areas such as substantia nigra, ventricles, middle temporal gyrus, and olfactory bulb.

Interestingly, ACE2 in neuron tissue is expressed not only on the surface but also in the cytoplasm. This finding could imply that SARS-CoV-2 can infect neuronal and glial cells in all parts of the central nervous system.

How does neuroinvasion occur with SARS-CoV-2?

Current knowledge indicates the possibility of nerve cell virus invasion by several mechanisms. These include the transfer of viruses across synapses of infected cells, entering the brain through the olfactory nerve, infection of endothelial blood vessels, and migration of infected white blood cells across the blood-brain barrier (BBB).

The corona virus has been shown to spread back along the nerves from the edge of the peripheral nerves, across synapses, and thus into the brain, in several small animal studies. This is facilitated by a pathway for endocytosis or exocytosis between motor cortex neurons, and other secretory vesicular pathways between neurons and satellite cells.

Axonal transport occurs rapidly using axonal microtubules, which allow the virus to reach the body of neuron cells with a retrograde version of this mechanism.

The possibility of spreading the olfactory route is marked by the occurrence of isolated anosmia and age. In such cases, the virus can pass through the latticed plate to enter the central nervous system (CNS) of the nose. However, more recent unpublished research shows that olfactory neurons lack ACE2, whereas cells in the olfactory epithelium do so. This could mean that a viral injury to the olfactory epithelium, and not the olfactory neuron, is responsible for anosmia, but further studies will be needed to confirm this.

Cross the BBB

This virus can also pass through the BBB through two separate mechanisms. In the first case, infected vascular endothelial cells can move the virus across blood vessels to neurons. Once there, the virus can start to bud and infect more cells.

The second mechanism is through infected white blood cells that pass through the BBB – a mechanism called Trojan horse, which is famous for its role in HIV. Inflamed BBB allows the entry of immune cells and cytokines, and even, possibly, viral particles into the brain. T-lymphocytes, however, do not allow viruses to replicate even though they can be infected.

Neurological features of COVID-19

From limited data on neurological manifestations related to COVID-19, it is clear that headaches, anosmia, and age are among the most common symptoms. However, other findings include stroke and an abnormal state of consciousness.

While headaches occur in up to one third of confirmed cases, anosmia or age shows a much more varied prevalence. In Italy, about one fifth of cases show this symptom, while almost 90% of patients in Germany have such symptoms.

The researchers said, “Given the reports of anosmia that appear as early symptoms of COVID-19, specific testing for anosmia can offer the potential for early detection of COVID-19 infection.”

Impaired consciousness can occur in up to 37% of patients, due to various mechanisms such as infection and direct brain injury, metabolic-toxic encephalopathy, and demyelinating disease. Encephalitis has not been documented as a result of COVID-19.

Toxic-metabolic encephalopathy can occur due to a number of disorders of metabolic and endocrine function. These include electrolyte and mineral imbalances, kidney disorders, and cytokine storms, hypo or hyperglycemia, and liver dysfunction. Patients who are elderly, ill, or already have symptoms of dementia, or are malnourished, are at higher risk for this condition.

Less common neurological complications include Guillain-Barre syndrome, which is a post-viral acute inflammatory demyelinating disease, and cerebrovascular events, including stroke.

Is COVID-19 Therapy Related to Neurological Manifestations?

Nowadays, many different drugs are used to treat this condition.

Chloroquine and hydroxychloroquine, for example, can cause psychosis, peripheral neuropathy, and the latter can worsen the symptoms of myasthenia gravis. Tocilizumab, an IL-6 blocker, is intended to reduce excessive cytokine release that occurs in severe inflammation. Although admission to CNS is limited, it can sometimes cause headaches and dizziness.

Precautions for COVID-19 Patients with Neurological Conditions

If a patient already has a neurological condition that requires special treatment, they tend to be at higher risk for COVID-19, due to existing lung, heart, or liver conditions, having kidney disease (dialysis), if they are overweight, or at immunosuppressive drugs. Also, it is likely that they may be in nursing homes, where many countries have reported severe outbreaks.

This study concludes: “Doctors must continue to monitor patients closely for neurological diseases. Early detection of neurological deficits can lead to improved clinical outcomes and better treatment algorithms. “

Journal reference:

  • Zubair, A. S. et al. (2020). Neuropathogenesis and Neurological Manifestations of Coronavirus in the Coronavirus Era 2019: Overview. JAMA Neurology. doi: 10.1001 / jamaneurol.2020.2065.


image source

Researchers show how bats carry the MERS coronavirus | Instant News

The University of Saskatchewan (USask) research team has revealed how bats can carry Middle Eastern respiratory syndrome (MERS) coronavirus without getting sick – research that can explain how corona virus make the jump to humans and other animals.

Corona viruses such as MERS, Severe Acute Respiratory Syndrome (SARS), and more recently the SARS-CoV-2 virus that causes COVID19, are thought to originate from bats. Although these viruses can cause serious and often fatal diseases in humans, for reasons not previously well understood, bats do not appear to be injured.

Bats do not get rid of viruses and do not get sick. We want to understand why the MERS virus doesn’t kill the bat’s immune response like humans do, “

Vikram Misra, USask Microbiologist, University of Saskatchewan

In a new study published in Scientific Report, the team has shown for the first time that cells from insect-eating bats can be continuously infected with the MERS corona virus for months, because of the important adaptation of bats and viruses that work together.

“Instead of killing bat cells as viruses do with human cells, the MERS coronavirus enters a long-term relationship with the host, which is maintained by the bat’s unique” super “immune system,” said Misra, the corresponding author in the newspaper. “SARS-CoV-2 is estimated to operate in the same way.”

Misra said teamwork showed that pressure on bats – such as wet markets, other diseases, and possible loss of habitat – might have a role in spreading the corona virus to other species.

“When bats experience stress on their immune system, it disrupts the balance of the immune-virus system and allows the virus to multiply,” he said.

The research was conducted at the USask Vaccine and Infectious Disease Organization – International Vaccine Center (VIDO-InterVac), one of the largest level 3 detention research facilities in the world, by a team of researchers from USask College of Veterinary Medicine and VIDO-InterVac.

“We see that MERS coronaviruses can quickly adapt to certain niches, and although we don’t fully understand what’s happening, this shows how coronaviruses can jump from species to species so easily,” said VIDO-InterVac scientist Darryl Falzarano, who led the bat study, developed the first potential treatment for MERS-CoV, and led the VIDO-InterVac effort to develop a vaccine against COVID-19.

So far, the SARS-CoV-2 virus has infected more than 3.5 million people worldwide and killed seven percent of those infected. In contrast, the MERS virus infected nearly 2,500 people in 2012 but killed one out of every three infected. There is no vaccine for SARS-CoV-2 or MERS. While camels are known as MERS-CoV brokers, bats are thought to be ancestral hosts.

Corona viruses quickly adapt to the species they are infected with, Misra said, but little is known about the molecular interactions of these viruses with their natural bat hosts. A study led by USask 2017 shows that bat coronaviruses can survive in their natural bat host for at least four months of hibernation.

When exposed to the MERS virus, bat cells adapt – not by producing inflammatory proteins that are a sign of illness, but by maintaining a natural antiviral response, a function that is turned off in other species, including humans. Simultaneously, the MERS virus also adapts to bat host cells very quickly to mutate one particular gene, he said.

Operating together, this adaptation produces the virus that is left in the long run in bats but is considered harmless until something – such as a disease or other stress trigger – disturbs this delicate balance.

Next, the team will shift its focus to understanding how the MERS virus borne by bats adapts to infection and replication in camels (a group of even-ended ungulates that include camels) and human cells.

“This information may be important for predicting the next bat virus that will cause a pandemic,” Misra said.


Journal reference:

Banerjee, A., et al. (2020) Selection of viral variants during persistent infection of insect-eating bat cells with Middle Eastern syndrome coronavirus. Scientific Report. doi.org/10.1038/s41598-020-64264-1.


image source